Conditions: Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2020
Healthy volunteers: no

Brief summary:
This study will establish the safety as well as demonstrate benefit of the addition of a LABA to an ICS by utilizing an endpoint (time to first severe asthma exacerbation) that informs on both safety and efficacy.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Fluticasone Furoate/GW642444 intervention 2: Fluticasone furoate
Intervention descriptions: intervention 1: Combination inhaled corticosteroid and long-acting beta2-agonist intervention 2: Inhaled corticosteroid

Protocol document: